bioMérieux - First Quarter 2010 Business Review

21 April, 2010

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2010.

Net sales for the first quarter amounted to €307 million, up 6.4% at constant exchange rates and scope of consolidation (on a like-for-like basis) versus the first quarter of 2009.

Sales up 6.4% at constant exchange rates and scope of consolidation.

Download the Complete Press Release:

Pioneering Diagnostics